Li Ka Shing-Backed Cancer Drug Developer Delays Launch of Hong Kong Listing

Jun 18 2019, 5:56 AMJun 18 2019, 11:34 AMJune 18 2019, 5:56 AMJune 18 2019, 11:34 AM

(Bloomberg) -- Hutchison China MediTech Ltd., a cancer drug developer backed by billionaire Li Ka-shing, is delaying the launch of its Hong Kong share sale that could raise about $500 million, peop...